EnteroMedics Inc. (ETRM)
-NasdaqCM 1.04 
0.03(2.97%) 3:37PM EDT - Nasdaq Real Time Price
| Prev Close: | 1.01 |
|---|
| Open: | 1.01 |
|---|
| Bid: | 1.04 x 3000 |
|---|
| Ask: | 1.05 x 1700 |
|---|
| 1y Target Est: | 2.63 |
|---|
| Beta: | 1.92 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 1.00 - 1.07 |
|---|
| 52wk Range: | 0.81 - 4.40 |
|---|
| Volume: | 496,729 |
|---|
| Avg Vol (3m): | 530,962 |
|---|
| Market Cap: | 57.84M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.58 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- EnteroMedics to Participate in the Craig-Hallum Annual Institutional Investor ConferenceMarketwired(Wed, May 22)
- 4 Stocks Under $10 Spiking Higherat TheStreet(Tue, May 21)
- ENTEROMEDICS INC FinancialsEDGAR Online Financials(Fri, May 17)
- J.C. Penney Reports Its Earnings, Amazon Faces British Parliament, and 3 More Hot Stocksat Wall St. Cheat Sheet(Fri, May 17)
- EnteroMedics completes VBLOC therapy pre-PMA meeting with FDAtheflyonthewall.com(Fri, May 17)
- EnteroMedics Completes VBLOC Therapy Pre-PMA Meeting With FDAMarketwired(Fri, May 17)
- ENTEROMEDICS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard;EDGAR Online(Fri, May 17)
- ENTEROMEDICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Submission of Matters to a Vote of SEDGAR Online(Mon, May 13)
- ENTEROMEDICS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 10)
- EnteroMedics Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, May 1)
- ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Wed, May 1)
- Q1 2013 EnteroMedics Inc Earnings Release - Time Not SuppliedCCBN(Wed, May 1)
- EnteroMedics Reports First Quarter 2013 Financial ResultsMarketwired(Wed, May 1)
- EnteroMedics to Host First Quarter 2013 Financial Results Conference Call and Provide Business UpdateMarketwired(Mon, Apr 22)
- EnteroMedics to Present at 25th Annual Roth Capital Partners ConferenceMarketwired(Tue, Mar 12)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 298.16 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.42 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.12 |
|---|
| Mean Recommendation*: | 1.8 |
|---|
| PEG Ratio (5 yr expected): | 0.25 |
|---|
Business Summary
EnteroMedics Inc., a development stage medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.
View More